ZALEPLON Drug Record
-
ZALEPLON chembl:CHEMBL1521 Approved
Alternate Names:
LJC-10846 L-846 ZAL-846 LJC 10846 CL-284846 SONATA SKP-1041 ZALEPLON CIV ZALEPLON L846 SONATA® 3'-(3-CYANOPYRAZOLO(1,5-A)PYRIMIDIN-7-YL)-N-ETHYLACETANILIDE rxcui:74667 pubchem.compound:5719 chemidplus:151319-34-5 chembl:CHEMBL1521 drugbank:00962 Drug Info:
Drug Class hypnotics and sedatives Year of Approval 1999 FDA Approval approved Drug Class Small Molecule Drug Indications hypnotic Publications:
-
Interaction Types & Directionality:
n/a Interaction Info:
Trial Name AZ-007, Staccato zaleplon Novel drug target Established target Trial Name SKP-1041, delayed-release zaleplon -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Direct Interaction yes Mechanism of Interaction GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator Trial Name AZ-007, Staccato zaleplon
Sources:
TdgClinicalTrial ChemblInteractions TEND TTD -
Interaction Types & Directionality:
positive modulator (activating) Interaction Info:
Mechanism of Interaction GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator Direct Interaction yes -
Interaction Types & Directionality:
positive modulator (activating) Interaction Info:
Mechanism of Interaction GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator Direct Interaction yes
-
Alternate Names:
ZALEPLON Primary Drug Name Drug Info:
Year of Approval 1999 Drug Class hypnotics and sedatives Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications hypnotic Drug Class Small Molecule FDA Approval approved Publications:
-
Alternate Names:
D09DWL TTD Drug ID Drug Info:
Publications:
-
- Version: ChEMBL_27
Alternate Names:
Drug Info:
Publications:
-
- Version: chembl_23
Alternate Names:
Drug Info:
Publications: